Stephen R. Fussell, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 196,550 shares at $46.00 ($9.0M) on 2017-06-08, disclosed to the SEC on 2017-06-09.
Scheduled sale ($9.0M) by Executive Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.00 | 195,700 | $9.0M | 99.6% |
| 2 | $46.01 | 300 | $14K | 0.2% |
| 3 | $46.02 | 500 | $23K | 0.3% |
| 4 | $46.93 | 50 | $2K | 0.0% |
| Total | $46.00 avg | 196,550 | $9.0M | 100% |
| Filing → |
| ABT | SELL | 2018-03-02 | $668K | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.2M | — | Filing → |
| ABT | SELL | 2018-02-21 | $3.9M | — | Filing → |